Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-13-136909
Filing Date
2013-04-01
Accepted
2013-04-01 17:16:33
Documents
7
Period of Report
2012-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K d513410d10k.htm 10-K 1370422
2 EX-10.20 d513410dex1020.htm EX-10.20 21373
3 EX-10.21 d513410dex1021.htm EX-10.21 495047
4 EX-31.1 d513410dex311.htm EX-31.1 7120
5 EX-31.2 d513410dex312.htm EX-31.2 6807
6 EX-32.1 d513410dex321.htm EX-32.1 4848
7 GRAPHIC g513410ex10_21pg001.jpg GRAPHIC 14974
  Complete submission text file 0001193125-13-136909.txt   1927396
Mailing Address 303B COLLEGE ROAD EAST PRINCETON NJ 08540
Business Address 303B COLLEGE ROAD EAST PRINCETON NJ 08540 (609) 243-0123
Celator Pharmaceuticals Inc (Filer) CIK: 0001327467 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-54852 | Film No.: 13732320
SIC: 2834 Pharmaceutical Preparations